Drug Availability

HPS Pharmacies wish to give notice that Pfizer Australia Pty Ltd is experiencing an interruption to the supply of methotrexate vials as follows:

Pfizer Methotrexate Vials
Methotrexate 50mg/2ml
ARTG 10777

DBL™ Methotrexate Vials
Methotrexate 50mg/2ml
ARTG 16314

The supply interruption is due to a manufacturing delay. Normal supplies are expected to resume in mid-November for the DBL™ product, and late-November 2017 for the Pfizer product.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 629 921.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates